LOW PREVALENCE OF HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS UNITS: EFFECT OF ISOLATION?

Hepatitis C virus (HCV) infection has recently become the major cause of chronic liver disease among patients on chronic hemodialysis. The use of erythropoietin for treatment of anemia has reduced the number of blood transfusions, but the frequency of HCV infection has not declined in hemodialysis u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Renal failure 2002-01, Vol.24 (5), p.639-644
Hauptverfasser: Harmankaya, Özlem, Çetin, Birsen, Öbek, Aydo an, Seber, Engin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 644
container_issue 5
container_start_page 639
container_title Renal failure
container_volume 24
creator Harmankaya, Özlem
Çetin, Birsen
Öbek, Aydo an
Seber, Engin
description Hepatitis C virus (HCV) infection has recently become the major cause of chronic liver disease among patients on chronic hemodialysis. The use of erythropoietin for treatment of anemia has reduced the number of blood transfusions, but the frequency of HCV infection has not declined in hemodialysis units. The exact mode of transmission of HCV within dialysis units is as yet incompletely defined, but there is evidence to support nosocomial transmission by sharing dialysis machines in the hemodialysis unit. We performed a study to estimate the prevalence of HCV infection in our hemodialysis unit and to evaluate the effect of patient isolation and use of devoted dialysis machines for HCV-positive patients on the spread of HCV infection. A total of 168 patients on chronic hemodialysis (92 males and 76 females; mean age 54 ± 12) were screened for HCV-antibodies (HCV-Ab) before their admission to the dialysis unit. Seropositive patients were isolated and confined to dedicated dialysis machines. Aminotransferases were measured monthly and HCV-Ab screening was performed second or third generation ELISA test every two months. Seropositive patients were tested by the PCR for the detection of HCV-RNA. Between March 1992 and August 2000, eight of 168 patients showed seroconversion. Seropositive patients were also found HCV-RNA positive. Four of these patients have become seropositive after they had undergone hemodialysis in other dialysis centers on holiday, two patients had received blood transfusions within the six months preceding seroconversion. The prevalence of HCV positivity in our hemodialysis unit is 4.7%. The low prevalence of HCV infection of our unit suggests that patient isolation and use of dedicated dialysis machines for seropositive patients decrease the transmission of HCV infection in hemodialysis units.
doi_str_mv 10.1081/JDI-120013968
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1081_JDI_120013968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72174744</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-7c56c707ace3492d8de06cfde92ef63033d7b88880aa820693f85d37bb9c04b3</originalsourceid><addsrcrecordid>eNp10M1LwzAYBvAgis7p0av0ordqPtom9SKldhqpq9j6dQppmuKkWzXZEP97MzYVD-aSQH7vw8sDwAGCJwgydHp9wX2EIUQkjtgGGKAQh34Eg3gTDCBjkQ8xftoBu9a-OhQyirfBDsKEwRjBAXjOi0fv9i57SPJsnGZeMfKustuk4hUvvdR74Hf3pcfHoyyteDF2L_d9U1zwJH8unbgf86o887LREiyHeVnkyZKe74GtVnZW76_vIahGWZVe-XlxydMk91UQhnOfqjBSFFKpNAli3LBGw0i1jY6xbiMCCWlozdyBUjIMo5i0LGwIretYwaAmQ3C8in0z_ftC27mYTqzSXSdnul9YQTGiAQ0CB_0VVKa31uhWvJnJVJpPgaBYVilcleKnSucP18GLeqqbX73uzoGjNZBWya41cqYm9teROIhCFzYEbOUms7Y3U_nRm64Rc_nZ9eZ7iPy3A_0z-qJlN39R0mjx2i_MzPX6z_ZfakKXZg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72174744</pqid></control><display><type>article</type><title>LOW PREVALENCE OF HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS UNITS: EFFECT OF ISOLATION?</title><source>MEDLINE</source><source>Taylor &amp; Francis Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Harmankaya, Özlem ; Çetin, Birsen ; Öbek, Aydo an ; Seber, Engin</creator><creatorcontrib>Harmankaya, Özlem ; Çetin, Birsen ; Öbek, Aydo an ; Seber, Engin</creatorcontrib><description>Hepatitis C virus (HCV) infection has recently become the major cause of chronic liver disease among patients on chronic hemodialysis. The use of erythropoietin for treatment of anemia has reduced the number of blood transfusions, but the frequency of HCV infection has not declined in hemodialysis units. The exact mode of transmission of HCV within dialysis units is as yet incompletely defined, but there is evidence to support nosocomial transmission by sharing dialysis machines in the hemodialysis unit. We performed a study to estimate the prevalence of HCV infection in our hemodialysis unit and to evaluate the effect of patient isolation and use of devoted dialysis machines for HCV-positive patients on the spread of HCV infection. A total of 168 patients on chronic hemodialysis (92 males and 76 females; mean age 54 ± 12) were screened for HCV-antibodies (HCV-Ab) before their admission to the dialysis unit. Seropositive patients were isolated and confined to dedicated dialysis machines. Aminotransferases were measured monthly and HCV-Ab screening was performed second or third generation ELISA test every two months. Seropositive patients were tested by the PCR for the detection of HCV-RNA. Between March 1992 and August 2000, eight of 168 patients showed seroconversion. Seropositive patients were also found HCV-RNA positive. Four of these patients have become seropositive after they had undergone hemodialysis in other dialysis centers on holiday, two patients had received blood transfusions within the six months preceding seroconversion. The prevalence of HCV positivity in our hemodialysis unit is 4.7%. The low prevalence of HCV infection of our unit suggests that patient isolation and use of dedicated dialysis machines for seropositive patients decrease the transmission of HCV infection in hemodialysis units.</description><identifier>ISSN: 0886-022X</identifier><identifier>EISSN: 1525-6049</identifier><identifier>DOI: 10.1081/JDI-120013968</identifier><identifier>PMID: 12380910</identifier><identifier>CODEN: REFAE8</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Emergency and intensive care: renal failure. Dialysis management ; Female ; HCV infection ; Hemodialysis units ; Hemodialysis Units, Hospital - statistics &amp; numerical data ; Hepatitis C - epidemiology ; Hepatitis C - etiology ; Hepatitis C - transmission ; Hepatitis C Antibodies - blood ; Humans ; Intensive care medicine ; Kidney Failure, Chronic - blood ; Kidney Failure, Chronic - therapy ; Male ; Medical sciences ; Middle Aged ; Patient isolation ; Patient Isolation - statistics &amp; numerical data ; Prevalence ; Renal Dialysis - adverse effects ; Renal Dialysis - statistics &amp; numerical data ; Transaminases - blood</subject><ispartof>Renal failure, 2002-01, Vol.24 (5), p.639-644</ispartof><rights>2002 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2002</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-7c56c707ace3492d8de06cfde92ef63033d7b88880aa820693f85d37bb9c04b3</citedby><cites>FETCH-LOGICAL-c455t-7c56c707ace3492d8de06cfde92ef63033d7b88880aa820693f85d37bb9c04b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1081/JDI-120013968$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1081/JDI-120013968$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,59645,60434,61219,61400</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13946501$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12380910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harmankaya, Özlem</creatorcontrib><creatorcontrib>Çetin, Birsen</creatorcontrib><creatorcontrib>Öbek, Aydo an</creatorcontrib><creatorcontrib>Seber, Engin</creatorcontrib><title>LOW PREVALENCE OF HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS UNITS: EFFECT OF ISOLATION?</title><title>Renal failure</title><addtitle>Ren Fail</addtitle><description>Hepatitis C virus (HCV) infection has recently become the major cause of chronic liver disease among patients on chronic hemodialysis. The use of erythropoietin for treatment of anemia has reduced the number of blood transfusions, but the frequency of HCV infection has not declined in hemodialysis units. The exact mode of transmission of HCV within dialysis units is as yet incompletely defined, but there is evidence to support nosocomial transmission by sharing dialysis machines in the hemodialysis unit. We performed a study to estimate the prevalence of HCV infection in our hemodialysis unit and to evaluate the effect of patient isolation and use of devoted dialysis machines for HCV-positive patients on the spread of HCV infection. A total of 168 patients on chronic hemodialysis (92 males and 76 females; mean age 54 ± 12) were screened for HCV-antibodies (HCV-Ab) before their admission to the dialysis unit. Seropositive patients were isolated and confined to dedicated dialysis machines. Aminotransferases were measured monthly and HCV-Ab screening was performed second or third generation ELISA test every two months. Seropositive patients were tested by the PCR for the detection of HCV-RNA. Between March 1992 and August 2000, eight of 168 patients showed seroconversion. Seropositive patients were also found HCV-RNA positive. Four of these patients have become seropositive after they had undergone hemodialysis in other dialysis centers on holiday, two patients had received blood transfusions within the six months preceding seroconversion. The prevalence of HCV positivity in our hemodialysis unit is 4.7%. The low prevalence of HCV infection of our unit suggests that patient isolation and use of dedicated dialysis machines for seropositive patients decrease the transmission of HCV infection in hemodialysis units.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>HCV infection</subject><subject>Hemodialysis units</subject><subject>Hemodialysis Units, Hospital - statistics &amp; numerical data</subject><subject>Hepatitis C - epidemiology</subject><subject>Hepatitis C - etiology</subject><subject>Hepatitis C - transmission</subject><subject>Hepatitis C Antibodies - blood</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Kidney Failure, Chronic - blood</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Patient isolation</subject><subject>Patient Isolation - statistics &amp; numerical data</subject><subject>Prevalence</subject><subject>Renal Dialysis - adverse effects</subject><subject>Renal Dialysis - statistics &amp; numerical data</subject><subject>Transaminases - blood</subject><issn>0886-022X</issn><issn>1525-6049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10M1LwzAYBvAgis7p0av0ordqPtom9SKldhqpq9j6dQppmuKkWzXZEP97MzYVD-aSQH7vw8sDwAGCJwgydHp9wX2EIUQkjtgGGKAQh34Eg3gTDCBjkQ8xftoBu9a-OhQyirfBDsKEwRjBAXjOi0fv9i57SPJsnGZeMfKustuk4hUvvdR74Hf3pcfHoyyteDF2L_d9U1zwJH8unbgf86o887LREiyHeVnkyZKe74GtVnZW76_vIahGWZVe-XlxydMk91UQhnOfqjBSFFKpNAli3LBGw0i1jY6xbiMCCWlozdyBUjIMo5i0LGwIretYwaAmQ3C8in0z_ftC27mYTqzSXSdnul9YQTGiAQ0CB_0VVKa31uhWvJnJVJpPgaBYVilcleKnSucP18GLeqqbX73uzoGjNZBWya41cqYm9teROIhCFzYEbOUms7Y3U_nRm64Rc_nZ9eZ7iPy3A_0z-qJlN39R0mjx2i_MzPX6z_ZfakKXZg</recordid><startdate>20020101</startdate><enddate>20020101</enddate><creator>Harmankaya, Özlem</creator><creator>Çetin, Birsen</creator><creator>Öbek, Aydo an</creator><creator>Seber, Engin</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020101</creationdate><title>LOW PREVALENCE OF HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS UNITS: EFFECT OF ISOLATION?</title><author>Harmankaya, Özlem ; Çetin, Birsen ; Öbek, Aydo an ; Seber, Engin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-7c56c707ace3492d8de06cfde92ef63033d7b88880aa820693f85d37bb9c04b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>HCV infection</topic><topic>Hemodialysis units</topic><topic>Hemodialysis Units, Hospital - statistics &amp; numerical data</topic><topic>Hepatitis C - epidemiology</topic><topic>Hepatitis C - etiology</topic><topic>Hepatitis C - transmission</topic><topic>Hepatitis C Antibodies - blood</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Kidney Failure, Chronic - blood</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Patient isolation</topic><topic>Patient Isolation - statistics &amp; numerical data</topic><topic>Prevalence</topic><topic>Renal Dialysis - adverse effects</topic><topic>Renal Dialysis - statistics &amp; numerical data</topic><topic>Transaminases - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harmankaya, Özlem</creatorcontrib><creatorcontrib>Çetin, Birsen</creatorcontrib><creatorcontrib>Öbek, Aydo an</creatorcontrib><creatorcontrib>Seber, Engin</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Renal failure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harmankaya, Özlem</au><au>Çetin, Birsen</au><au>Öbek, Aydo an</au><au>Seber, Engin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LOW PREVALENCE OF HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS UNITS: EFFECT OF ISOLATION?</atitle><jtitle>Renal failure</jtitle><addtitle>Ren Fail</addtitle><date>2002-01-01</date><risdate>2002</risdate><volume>24</volume><issue>5</issue><spage>639</spage><epage>644</epage><pages>639-644</pages><issn>0886-022X</issn><eissn>1525-6049</eissn><coden>REFAE8</coden><abstract>Hepatitis C virus (HCV) infection has recently become the major cause of chronic liver disease among patients on chronic hemodialysis. The use of erythropoietin for treatment of anemia has reduced the number of blood transfusions, but the frequency of HCV infection has not declined in hemodialysis units. The exact mode of transmission of HCV within dialysis units is as yet incompletely defined, but there is evidence to support nosocomial transmission by sharing dialysis machines in the hemodialysis unit. We performed a study to estimate the prevalence of HCV infection in our hemodialysis unit and to evaluate the effect of patient isolation and use of devoted dialysis machines for HCV-positive patients on the spread of HCV infection. A total of 168 patients on chronic hemodialysis (92 males and 76 females; mean age 54 ± 12) were screened for HCV-antibodies (HCV-Ab) before their admission to the dialysis unit. Seropositive patients were isolated and confined to dedicated dialysis machines. Aminotransferases were measured monthly and HCV-Ab screening was performed second or third generation ELISA test every two months. Seropositive patients were tested by the PCR for the detection of HCV-RNA. Between March 1992 and August 2000, eight of 168 patients showed seroconversion. Seropositive patients were also found HCV-RNA positive. Four of these patients have become seropositive after they had undergone hemodialysis in other dialysis centers on holiday, two patients had received blood transfusions within the six months preceding seroconversion. The prevalence of HCV positivity in our hemodialysis unit is 4.7%. The low prevalence of HCV infection of our unit suggests that patient isolation and use of dedicated dialysis machines for seropositive patients decrease the transmission of HCV infection in hemodialysis units.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><pmid>12380910</pmid><doi>10.1081/JDI-120013968</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0886-022X
ispartof Renal failure, 2002-01, Vol.24 (5), p.639-644
issn 0886-022X
1525-6049
language eng
recordid cdi_crossref_primary_10_1081_JDI_120013968
source MEDLINE; Taylor & Francis Journals Complete; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Aged, 80 and over
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Emergency and intensive care: renal failure. Dialysis management
Female
HCV infection
Hemodialysis units
Hemodialysis Units, Hospital - statistics & numerical data
Hepatitis C - epidemiology
Hepatitis C - etiology
Hepatitis C - transmission
Hepatitis C Antibodies - blood
Humans
Intensive care medicine
Kidney Failure, Chronic - blood
Kidney Failure, Chronic - therapy
Male
Medical sciences
Middle Aged
Patient isolation
Patient Isolation - statistics & numerical data
Prevalence
Renal Dialysis - adverse effects
Renal Dialysis - statistics & numerical data
Transaminases - blood
title LOW PREVALENCE OF HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS UNITS: EFFECT OF ISOLATION?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A02%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LOW%20PREVALENCE%20OF%20HEPATITIS%20C%20VIRUS%20INFECTION%20IN%20HEMODIALYSIS%20UNITS:%20EFFECT%20OF%20ISOLATION?&rft.jtitle=Renal%20failure&rft.au=Harmankaya,%20%C3%96zlem&rft.date=2002-01-01&rft.volume=24&rft.issue=5&rft.spage=639&rft.epage=644&rft.pages=639-644&rft.issn=0886-022X&rft.eissn=1525-6049&rft.coden=REFAE8&rft_id=info:doi/10.1081/JDI-120013968&rft_dat=%3Cproquest_cross%3E72174744%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72174744&rft_id=info:pmid/12380910&rfr_iscdi=true